132 related articles for article (PubMed ID: 30229832)
41. Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma.
Zhu G; Wang S; Chen J; Wang Z; Liang X; Wang X; Jiang J; Lang J; Li L
Mol Carcinog; 2017 Oct; 56(10):2210-2222. PubMed ID: 28485478
[TBL] [Abstract][Full Text] [Related]
42. CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.
Costa EFD; Lopes-Aguiar L; Nogueira GS; Lima TRP; Rinck-Junior JA; Lourenço GJ; Lima CSP
Head Neck; 2019 Aug; 41(8):2665-2670. PubMed ID: 30903678
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-101 polymorphisms and risk of head and neck squamous cell carcinoma in a Chinese population.
Miao L; Wang L; Yuan H; Hang D; Zhu L; Du J; Zhu X; Li B; Wang R; Ma H; Chen N
Tumour Biol; 2016 Mar; 37(3):4169-74. PubMed ID: 26490987
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA C5orf66-AS1 prevents oral squamous cell carcinoma through inhibiting cell growth and metastasis.
Lu T; Liu H; You G
Int J Mol Med; 2018 Dec; 42(6):3291-3299. PubMed ID: 30280186
[TBL] [Abstract][Full Text] [Related]
45. A Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population.
Gao C; Wang J; Li C; Zhang W; Liu G
PLoS One; 2016; 11(9):e0160801. PubMed ID: 27622501
[TBL] [Abstract][Full Text] [Related]
46. SCCA, TSGF, and the Long Non-Coding RNA AC007271.3 are Effective Biomarkers for Diagnosing Oral Squamous Cell Carcinoma.
Shao T; Huang J; Zheng Z; Wu Q; Liu T; Lv X
Cell Physiol Biochem; 2018; 47(1):26-38. PubMed ID: 29763905
[TBL] [Abstract][Full Text] [Related]
47. Revisiting the metallothionein genes polymorphisms and the risk of oral squamous cell carcinoma in a Brazilian population.
Rosa RR; Garcia MA; Alves PT; Sousa EM; Pimentel LS; Barbosa LD; Loyola AM; Goulart LR; Faria PC; Cardoso SV
Med Oral Patol Oral Cir Bucal; 2021 May; 26(3):e334-e340. PubMed ID: 33340085
[TBL] [Abstract][Full Text] [Related]
48. Impact of MDM2 single nucleotide polymorphism on oral squamous cell carcinoma risk.
Xie JL; Yang JL; Liu DS; Xie YG; Ji P
Cell Biochem Biophys; 2015 Mar; 71(2):993-8. PubMed ID: 25323564
[TBL] [Abstract][Full Text] [Related]
49. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
Saleem S; Azhar A; Hameed A; Khan MA; Abbasi ZA; Qureshi NR; Ajmal M
Oral Oncol; 2013 Aug; 49(8):818-23. PubMed ID: 23683469
[TBL] [Abstract][Full Text] [Related]
50. Association of Interleukin-10 (A1082G) gene polymorphism with Oral squamous cell carcinoma in north Indian population.
Hussain SR; Ahmad MK; Mahdi AA; Naqvi H; Ahmad MW; Srivastava S; Nigam K; Gupta S
J Genet; 2016 Jun; 95(2):249-55. PubMed ID: 27350666
[TBL] [Abstract][Full Text] [Related]
51. A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction.
Zhao C; Zou H; Wang J; Shen J; Liu H
DNA Cell Biol; 2018 Nov; 37(11):888-895. PubMed ID: 30234381
[TBL] [Abstract][Full Text] [Related]
52. Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese.
Chung YT; Hsieh LL; Chen IH; Liao CT; Liou SH; Chi CW; Ueng YF; Liu TY
Carcinogenesis; 2009 Feb; 30(2):286-94. PubMed ID: 19126640
[TBL] [Abstract][Full Text] [Related]
53. Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis.
Sun Z; Gao W; Cui JT
BMC Oral Health; 2018 Aug; 18(1):143. PubMed ID: 30126398
[TBL] [Abstract][Full Text] [Related]
54. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y
Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528
[TBL] [Abstract][Full Text] [Related]
55. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand.
Kietthubthew S; Sriplung H; Au WW; Ishida T
Int J Hyg Environ Health; 2006 Jan; 209(1):21-9. PubMed ID: 16373199
[TBL] [Abstract][Full Text] [Related]
56. Association of the XPD and XRCC3 gene polymorphisms with oral squamous cell carcinoma in a Northeastern Brazilian population: A pilot study.
dos Santos Pereira J; Fontes FL; de Medeiros SR; de Almeida Freitas R; de Souza LB; da Costa Miguel MC
Arch Oral Biol; 2016 Apr; 64():19-23. PubMed ID: 26742000
[TBL] [Abstract][Full Text] [Related]
57. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma.
Shieh TM; Chang KW; Tu HF; Shih YH; Ko SY; Chen YC; Liu CJ
Oral Oncol; 2010 Sep; 46(9):e47-53. PubMed ID: 20656543
[TBL] [Abstract][Full Text] [Related]
58. Association of matrix metalloproteinase-11 polymorphisms with susceptibility and clinicopathologic characteristics for oral squamous cell carcinoma.
Lin CW; Yang SF; Chuang CY; Lin HP; Hsin CH
Head Neck; 2015 Oct; 37(10):1425-31. PubMed ID: 24838924
[TBL] [Abstract][Full Text] [Related]
59. Implications of long non-coding RNAs (lncRNAs) in the treatment of oral squamous cell carcinoma (OSCC).
Sekar D
Oral Oncol; 2022 Apr; 127():105812. PubMed ID: 35279543
[No Abstract] [Full Text] [Related]
60. Effects of long noncoding RNA on prognosis of oral squamous cell carcinoma: A protocol for systematic review and meta analysis.
Lin Q; Zhang Y; Liu Y; Xu X
Medicine (Baltimore); 2021 Apr; 100(16):e25507. PubMed ID: 33879685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
